The US Department of Agriculture (USDA) has granted conditional approval for a vaccine to protect honey bees from American foulbrood (AFB), but it's how they administer it that has Australian researchers and beekeepers excited.
Developed by biotech company Dalan Animal Health, the vaccine contains dead whole cells of the Paenibacillus larvae bacteria, which causes AFB, and is expected to hit the US market this year.
